Top Pharm Lawsuit Claims Stories

Avandia Lawsuit Statute of Limitations Motion is Denied

Avandia MDL Judge Cynthia Ruth has denied a motion to dismiss over sixty Avandia Lawsuit claims for statute of limitations. GlaxoSmithKline, the maker of controversial diebietes durg, Avandia argued that patients should have been aware of Avandia side effects in May 2007. In May 07 the New England Journal of medicine released a study linking Avandia to side effects including Heart Attack and congestive heart failure. GSK is arguing that Avandia Lawsuit Statute of Limitations should have begun in May 2001.

Avandia Claims Statute of Limitations rules where these claims were file (Pennsylvania) is 2 years. In the ruling it was reported GSK argues that a “storm of media attention about Avandia in May-November 2007” should have put the plaintiffs on notice to investigate the cause of their injuries. The patients in this Avandia lawsuit reported argued they had now knowledge of the risks between Avandia and Avandia heart attack risk until 2010.

In the Avandia Lawsuit Statute of Limitations Ruling Judge Cynthia Rufe said in her order regarding Avandia MDL NO. 1871

"There is certainly a point at which a reasonable person was on notice to investigate the possibility of a connections between and injury and use of Avandia, but the Court cannot, on the present record, determine that point to be May 21, 2007"

FDA Reports Increased Risk of Blood Clots from Yaz Use

The FDA recently reported on September 27th, that it "remains concerned" that newer birth control devices such as Yaz may be linked to increased risk of Blood Clots. The FDA reports that women who use Yaz and other new birth control devices are at 150% more risk than women who don't use these devices. The FDA study reporting involved over 800,000 women.

In a statement released by the FDA, "The FDA is informing the public that it has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots for women who use drospirenone-containing birth control pills."

The FDA will hold another series of meetings around December 8th to further review Yaz side effects, lawsuits and claims.

FDA to Possibly Call for More Testing on Surgical Mesh Devices

The FDA meet for 2 days earlier in September to determine if vaginal mesh or surgical mesh may need to be reclassified as a "High Risk" medical device. Reportedly from these most recent Surgical Mesh FDA meetings, a number of surgical mesh manufactures agreed that future versions of surgical mesh should face more stringent testing. Also it was discussed that labeling changes should be made to Trans Vaginal Mesh in order to warn of side effects a patient can suffer. If the FDA does classify Surgical Mesh Devices as” high risk”, the marketers and the manufacturers of surgical mesh products will have to conduct studies on post market medical trends, and provide that information to the FDA to review.

Avandia Class Action Filed in Illinois

An Avandia Class Action lawsuit was filed in St. Clair County Circuit Court by 43 plaintiffs last month in the state of Illinois. The suit claims the 43 plaintiffs in the avandia class action were failed proper warning from GlaxoSmithKline regarding Avandia's side effects. Side effects of Avandia has included heart attack and congestive heart failure. Thousands of reported Avandia lawsuits have been filed throughout the country since Avandia (rosiglitazone) was introduced in 1998.

Avandia Class Action in Illinois

The latest class action lawsuit was entered on 5/4 and against GlaxoSmithKline, SmithKline Beecham Corporation, McKesson Corporation and five other defendants. The Avandia Class Action lawsuit claims that the Avandia manufacture is guilty of negligence, fraud, breach of warranty and misrepresentation. It's been reported this Avandia class action lawsuit is asking for Avandia claim damages in excess of $650,000.

Earlier this month the FDA decided to pull Avandia off the shelf starting this Nonmember. The controversial diabetes drug will only be available through a special program called the Avandia-rosiglitazone Medicines Access Program. A portion of the Avandia statement made by the FDA includes:

"The U.S. Food and Drug Administration (FDA) is informing the public of new restrictions to the prescribing and use of rosiglitazone-containing medicines. These medicines to treat type II diabetes are sold under the names Avandia, Avandamet, and Avandaryl. Healthcare providers and patients must enroll in a special program in order to prescribe and receive these drugs.

Ex-Glaxo Executive Is Charged in Drug Fraud

“This is absolutely precedent-setting — this is really going to set people’s hair on fire,” said Douglas B. Farquhar, a Washington lawyer who recently presided at a panel on law enforcement during a drug industry conference where federal officials warned they were focusing on individuals. “This is indicative of the F.D.A. and Justice strategy to go after the very top-ranking managing officials at regulated companies.”
Click here to read more...

Brent Coon & Associates Wins Multi-Million Dollar Lawsuit Against Wyeth & Upjohn (Pfizer)

A Little Rock jury found that Premarin used with Provera and Prempro caused Little Rock plaintiff Donna Scroggin’s breast cancer. Wyeth, Inc. and Upjohn, a division of Pfizer were ordered to pay $2.7 million in compensatory damages and $19.36 Million (Wyeth) $7 million in punitive damages (Upjohn) for a total of roughly $26 million.
Read more about this verdict.

The United States Federal Drug Administration (FDA) has issued a Public Health Advisory about the increased risk of suicidal thoughts and behaviors by people taking the smoking-cessation drug varenicline (Chantrix). This warning comes after confirming that 39 suicides have occurred in patients taking varenicline (Chantrix).
Learn More about Chantix.